Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy

Eye (Lond). 2020 Sep;34(9):1489-1490. doi: 10.1038/s41433-020-0802-7. Epub 2020 Feb 10.

Author

Srinivas R Sadda^{1

2}

Affiliations

¹ Doheny Eye Institute, Los Angeles, CA, USA. ssadda@doheny.org.
² Department of Ophthalmology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. ssadda@doheny.org.

No abstract available

Publication types

Editorial

MeSH terms

Central Serous Chorioretinopathy* / drug therapy
Eplerenone
Fluorescein Angiography
Humans
Mineralocorticoid Receptor Antagonists / therapeutic use
Spironolactone / therapeutic use
Tomography, Optical Coherence

Substances

Mineralocorticoid Receptor Antagonists
Spironolactone
Eplerenone